Project InformImportant note: Information in this article was accurate in January, 2003. The state of the art may have changed since the publication date.
Click here to return to Project Inform main menu
DonateNow
Print this Article

In the Dog House: Hoffman-La Roche


Project Inform Perspectives 35 - January, 2003


In the Dog House:
Hoffmann-La Roche, maker of saquinavir (Invirase and Fortovase) and ddC (HIVID) for setting the price of their new drug for hepatitis C, called Pegasys, even higher than that charged by Schering Plough for a similar drug.

Schering's price, at around $14,000 per year, was already so high that most people considered it immoral, but despite the impending crisis in funding for drugs, Roche topped them, charging nearly $15,000. Pegasys must be used in combination with a second drug, ribavirin, so the true price is higher still.

Want to tell them how you feel about this? Write or email:
George Abercrombie
President & CEO
Hoffmann-La Roche
340 Kingsland St.
Building 85, 8th Floor
Nutley, NJ 07110
george.abercrombie@roche.com

Next Article  |  Table of Contents

030101
PI030101


©2003. This document is copyrighted by Project Inform, 205 13th Street, #2001, San Francisco, CA 94103. Treatment Hotline: 800-822-7422 (toll-free) or 415-558-9051 (in the San Francisco Bay Area and internationally) All Project Inform materials may be reprinted and/or distributed without prior permission. However, reprints may not be edited and must include the following text: "From Project Inform, for more information contact the Project Inform National HIV/AIDS Treatment Hotline, 800-822-7422." For permission to edit any Project Inform material for further publication, contact David Evans at the Project Inform office.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1985, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS , or the party credited as the provider of the content.